Speaker Profile

MBA, CEO, MedySapiens, Inc.

Sanggoo Kang is CEO & founder of MedySapiens, Inc. pursuing perfect harmony of Biomedical and Data Science (Bioinformatics and Artificial Intelligence combined). Previously, Kang was COO/VP at DNA Link, one of the largest genomics service providers in Korea. After getting MBA from Duke in 1999, Kang worked for various companies in the US mostly in Hi-Tech marketing and business development area. They include 3M, Toshiba America, Samsung Electronics America, Nortel Networks and JP Morgan. Before coming to the US, Kang used to work for LG U+ as Telecom Engineer. Kang has Electrical Engineering BS degree from Seoul National University (Seoul, Korea) and MBA from Duke University. Kang has diversified background; Engineering and Business, Information & Communication Technology and Bio Tech, and global exposure.

AI and Data Science Showcase: MedySapiens, Inc.
MedySapiens provides solution to improve human’s Quality of Life thru ultimate harmony of Biomedical & Data Science (Bioinformatics and AI combined).

Cardiovascular Segmentation And Surgery Recommendation Using Deep-Learning
1. Stenosis detection & cardiovascular segmentation from cardio angiogram (dicom-formatted Xray) using deep learning, 2. Surgery recommendation of stent (PCI, Percutaneous Coronary Intervention, aka stent) vs.bypass (CABG, Coronary Artery Bypass Grafting) per Syntax Score.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.